China’s coronavirus vaccines are leaping ahead – but face challenges as virus wanes

David Cyranoski

Nature, 2020, vol. 584, issue 7819, 17-18

Abstract: Companies could struggle to enrol enough trial participants, or gather enough data to convince regulatory agencies that the shots work.

Keywords: Vaccines (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-020-02244-1 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:584:y:2020:i:7819:d:10.1038_d41586-020-02244-1

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-020-02244-1

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().